Authors pull study in The Lancet flagging hydroxychloroquine risks

Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health-care company that supplied the dataset.